✦ LIBER ✦

Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease

✍ Scribed by M.J. Goodrick; F. Daniel; A.G. Prentice; J.A. Copplestone; C.J. Tyrrell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MOPP chemotherapy for advanced Hodgkin's

✍ Melvin R. Moore; Stephen E. Jones; Joan M. Bull; Lawrence A. William; Saul A. Ro 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Adriamycin, bleomycin, DIC, CCNU, and pr

✍ Roger W. Rodgers; Jess F. Gamble; K. K. Loh; C. C. Shullenberger 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Supradiaphragmatic hodgkin's disease: Is

✍ Peter Mauch; Samuel Hellman 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 362 KB

No adverse effect of ABVD chemotherapy i

✍ Vlatko Pejša; Ivica Grgurević; Milan Kujundžić; Marko Martinović; Vladimir Stanč 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 69 KB

Sequential non-cross-resistant chemother

✍ D. J. Theo Wagener; J. Marion V. Burgers; Ad W. Dekker; Ismail Kazem; H. A. Van 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 1 views

Low acute hematological toxicity during

✍ O. Brosteanu; D. Hasenclever; M. Loeffler; V. Diehl; GermanHodgkin’sLymphomaStud 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 277 KB